A unicorn biopharma that ignores the traditional playbook, breaks development speed records, and chose Austin over the traditional biotech hubs. Mallory Factor, Founder and CEO of IntraBio, joins us to share how his Oxford-born company created an FDA-approved drug in record time while doing everything differently. In this wide-ranging conversation, we explore how finding unconventional talent, maintaining ruthless focus, and embracing a different mindset has led to transformational success in an industry resistant to change.
Episode Highlights
- Building a Different Kind of Biopharma Company
- Breaking Speed Records in Drug Development
- Finding Unconventional Talent
- Challenging Traditional Pharma Thinking
- Why Austin Over Boston and San Francisco
- The Power of Focus in Drug Development
- Austin's Creative Collisions and Future
- What's Next Austin?
- "Austin has some political problems that's going to have to clear up to make it a better city. Hopefully in time it will and it'll catapult it into the top five, six cities in America"
What is Austin Next?
Austin is building the new tech, cultural, and intellectual stack. The region is a living laboratory to answer a single question: How do you build a global innovation superpower?
Host Jason Scharf dissects innovation from the individual to the ecosystem. From the soundstage to the data center to the fab, we decode the mechanics of Austin's innovation ecosystem.
As Atoms, Bits, and Intelligence converge, we explore how Hard Tech scale, digital velocity, and creative density collide. This is an audit of the future. We map the physics of the flywheel so builders and investors can navigate the chaos.